Case Study: a Top 50 global pharmaceutical company accelerates target validation with Causaly

Top 50 Global Pharmaceutical Company cuts target validation from hours to minutes with Causaly

A neuroscientist at a top 50 global pharmaceutical company faced the challenge of accelerating and de-risking the lengthy process of target validation in drug discovery. The traditional method required extensive manual review of literature to assess biological rationale, safety risks, and therapeutic potential, which was slow and offered limited confidence in prioritization. To address this, she used Causaly.

Using Causaly's Agentic Research and Bio Graph, she was able to quickly surface the most relevant evidence and visually explore biological relationships for each target. This solution integrated mechanistic validation and competitive assessment into a single interface, dramatically reducing the time needed from hours to minutes. The impact, as reported by Causaly, was faster target prioritization, earlier identification of risk, and more confident, data-driven recommendations, which allowed her team to focus resources on the most viable candidates.